世界移植杂志(英文版)最新文献

{"title":"Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report.","authors":"Cristina Sirch, Niloufar Khanna, Lynda Frassetto, Francesco Bianco, Mary Louise Artero","doi":"10.5500/wjt.v12.i1.8","DOIUrl":"10.5500/wjt.v12.i1.8","url":null,"abstract":"<p><strong>Background: </strong>Acute intermittent porphyria (AIP) is an inherited disorder of porphyrin metabolism with a worldwide distribution and a prevalence ranging from 1 to 9 per million population. AIP is caused by an autosomal dominant-inherited mutation of low penetrance resulting in a deficiency of porphobilinogen deaminase (PBGD) activity. Acute attacks are provoked by stressors such as certain medications, alcohol, and infection. We herein present the first case report of AIP detected in a post-renal transplant patient.</p><p><strong>Case summary: </strong>The patient was a 65-year-old man who underwent transplantation 2 years previously for suspected nephroangiosclerosis and chronic interstitial nephro-pathy. He subsequently developed diabetes mellitus which required insulin therapy. He had been treated in the recent past with local mesalamine for proctitis. He presented with classic but common symptoms of AIP including intense abdominal pain, hypertension, and anxiety. He had multiple visits to the emergency room over a 6-mo period for these same symptoms before the diagnosis of AIP was entertained. His urinary postprandial blood glucose level was 60 mg/24 h (normal, < 2 mg/24 h). He was placed on a high carbohydrate diet, and his symptoms slowly improved.</p><p><strong>Conclusion: </strong>This case report describes a common presentation of an uncommon disease, in which post-transplant complications and medications may have contributed to precipitating the previously undiagnosed AIP. We hypothesize that the low-carbohydrate diet and insulin with which our patient was treated may have led to the attacks of AIP. Alternatively, our patient's mesalamine treatment for proctitis may have led to an acute AIP crisis. A high index of suspicion is needed to consider the diagnosis of a heme synthesis disorder, which presents with the common symptoms of abdominal pain, high blood pressure, and anxiety.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"12 1","pages":"8-14"},"PeriodicalIF":0.0,"publicationDate":"2022-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/35/WJT-12-8.PMC8771597.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39749930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area.","authors":"Isabela Dias Lauar,&nbsp;Luciana Costa Faria,&nbsp;Roberta Maia de Castro Romanelli,&nbsp;Wanessa Trindade Clemente","doi":"10.5500/wjt.v11.i12.512","DOIUrl":"https://doi.org/10.5500/wjt.v11.i12.512","url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing solid organ transplantation, particularly those who live or have lived in tuberculosis (TB) endemic areas, are at a high risk of developing TB. The majority of post-transplantation TB cases are associated with reactivation of latent TB infection (LTBI). Brazil is in a single position with overlapping areas of high TB endemicity and high transplant activity. In liver transplant (LT), one should be aware of the potential hepatotoxicity associated with the treatment regimens for LTBI.</p><p><strong>Aim: </strong>To evaluate the frequency of LTBI in LT patients and treatment-related issues.</p><p><strong>Methods: </strong>This was a retrospective analysis of a cohort of cirrhotic patients aged ≥ 18 years, who underwent LT at a high-complexity teaching hospital from January 2005 to December 2012.</p><p><strong>Results: </strong>Overall, 429 patients underwent LT during the study period. Of these, 213 (49.7%) underwent the tuberculin skin test (TST) during the pre-transplant period, and 35 (16.4%) of them had a positive result. The treatment for LTBI was initiated after LT in 12 (34.3%) of the TST-positive patients; in 3 (25.0%), treatment was maintained for at least 6 mo.</p><p><strong>Conclusion: </strong>The prevalence of LTBI was lower than expected. Initiation and completion of LTBI treatment was limited by difficulties in the management of these special patients.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 12","pages":"512-522"},"PeriodicalIF":0.0,"publicationDate":"2021-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/43/WJT-11-512.PMC8713304.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39962811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Solid organ transplantations and COVID-19 disease.","authors":"Emine Aylin Yılmaz,&nbsp;Öner Özdemir","doi":"10.5500/wjt.v11.i12.503","DOIUrl":"https://doi.org/10.5500/wjt.v11.i12.503","url":null,"abstract":"<p><p>Tens of thousands of people worldwide became infected with severe acute respiratory syndrome coronavirus-2. Death rate in the general population is about 1%-6%, but this rate rises up to 15% in those with comorbidities. Recent publications showed that the clinical progression of this disease in organ recipients is more destructive, with a fatality rate of up to 14%-25%. We aimed to review the effect of the pandemic on various transplantation patients. Coronavirus disease 2019 (COVID-19) has not only interrupted the lives of waiting list patients'; it has also impacted transplantation strategies, transplant surgeries and broken donation chains. COVID-19 was directly and indirectly accountable for a 73% surplus in mortality of this population as compared to wait listed patients in earlier years. The impact of chronic immunosuppression on outcomes of COVID-19 remains unclear but understanding the immunological mechanisms related to the virus is critically important for the lifetime of transplantation and immune suppressed patients. It is hard to endorse changing anti-rejection therapy, as the existing data evaluation is not adequate to advise substituting tacrolimus with cyclosporine during severe COVID-19 disease.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 12","pages":"503-511"},"PeriodicalIF":0.0,"publicationDate":"2021-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/1d/WJT-11-503.PMC8713305.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39962810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review.","authors":"Vishnu Jeyalan,&nbsp;Joshua Storrar,&nbsp;Henry H L Wu,&nbsp;Arvind Ponnusamy,&nbsp;Smeeta Sinha,&nbsp;Philip A Kalra,&nbsp;Rajkumar Chinnadurai","doi":"10.5500/wjt.v11.i11.480","DOIUrl":"https://doi.org/10.5500/wjt.v11.i11.480","url":null,"abstract":"<p><strong>Background: </strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can result in clinically significant multi-system disease including involvement in the kidney. The underlying histopathological processes were unknown at the start of the pandemic. As case reports and series have been published describing the underlying renal histopathology from kidney biopsies, we have started to gain an insight into the renal manifestations of this novel disease.</p><p><strong>Aim: </strong>To provide an overview of the current literature on the renal histopathological features and mechanistic insights described in association with coronavirus disease 2019 (COVID-19) infection.</p><p><strong>Methods: </strong>A systematic review was performed by conducting a literature search in the following websites-'PubMed', 'Web of Science', 'Embase' and 'Medline-ProQuest' with the following search terms-\"COVID-19 AND kidney biopsy\", \"COVID-19 AND renal biopsy\", \"SARS-CoV-2 AND kidney biopsy\" and \"SARS-CoV-2 AND renal biopsy\". We have included published data up until February 15, 2021, which includes kidney biopsies (native, transplant and postmortem) from patients with COVID-19. Data on clinical presentation, histopathological features, management and outcome was extracted from the reported studies.</p><p><strong>Results: </strong>The total number of biopsies reported on here is 288, of which 189 are postmortem, 84 native and 15 transplants. The results are varied and show underlying pathologies ranging from collapsing glomerulopathy and acute tubular injury (ATI) to anti-nuclear cytoplasmic antibody associated vasculitis and pigment nephropathy. There was variation in the specific treatment used for the various renal conditions, which included steroids, hydroxychloroquine, eculizumab, convalescent plasma, rituximab, anakinra, cyclophosphamide and renal replacement therapy, amongst others. The pathological process which occurs in the kidney following COVID-19 infection and leads to the described biopsy findings has been hypothesized in some conditions but not others (for example, sepsis related hypoperfusion for ATI). It is important to note that this represents a very small minority of the total number of cases of COVID-19 related kidney disease, and as such there may be inherent selection bias in the results described. Further work will be required to determine the pathogenetic link, if any, between COVID-19 and the other renal pathologies.</p><p><strong>Conclusion: </strong>This report has clinical relevance as certain renal pathologies have specific management, with the implication that kidney biopsy in the setting of renal disease and COVID-19 should be an early consideration, dependent upon the clinical presentation.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 11","pages":"480-502"},"PeriodicalIF":0.0,"publicationDate":"2021-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0d/9e/WJT-11-480.PMC8603634.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39694879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exercise training in heart transplantation.","authors":"Christos Kourek,&nbsp;Eleftherios Karatzanos,&nbsp;Serafim Nanas,&nbsp;Andreas Karabinis,&nbsp;Stavros Dimopoulos","doi":"10.5500/wjt.v11.i11.466","DOIUrl":"https://doi.org/10.5500/wjt.v11.i11.466","url":null,"abstract":"<p><p>Heart transplantation remains the gold standard in the treatment of end-stage heart failure (HF). Heart transplantation patients present lower exercise capacity due to cardiovascular and musculoskeletal alterations leading thus to poor quality of life and reduction in the ability of daily self-service. Impaired vascular function and diastolic dysfunction cause lower cardiac output while decreased skeletal muscle oxidative fibers, enzymes and capillarity cause arteriovenous oxygen difference, leading thus to decreased peak oxygen uptake in heart transplant recipients. Exercise training improves exercise capacity, cardiac and vascular endothelial function in heart transplant recipients. Pre-rehabilitation regular aerobic or combined exercise is beneficial for patients with end-stage HF awaiting heart transplantation in order to maintain a higher fitness level and reduce complications afterwards like intensive care unit acquired weakness or cardiac cachexia. All hospitalized patients after heart transplantation should be referred to early mobilization of skeletal muscles through kinesiotherapy of the upper and lower limbs and respiratory physiotherapy in order to prevent infections of the respiratory system prior to hospital discharge. Moreover, all heart transplant recipients after hospital discharge who have not already participated in an early cardiac rehabilitation program should be referred to a rehabilitation center by their health care provider. Although high intensity interval training seems to have more benefits than moderate intensity continuous training, especially in stable transplant patients, individualized training based on the abilities and needs of each patient still remains the most appropriate approach. Cardiac rehabilitation appears to be safe in heart transplant patients. However, long-term follow-up data is incomplete and, therefore, further high quality and adequately-powered studies are needed to demonstrate the long-term benefits of exercise training in this population.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 11","pages":"466-479"},"PeriodicalIF":0.0,"publicationDate":"2021-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/eb/WJT-11-466.PMC8603635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39694878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Current status of glucocorticoid usage in solid organ transplantation.","authors":"Simin Dashti-Khavidaki,&nbsp;Reza Saidi,&nbsp;Hong Lu","doi":"10.5500/wjt.v11.i11.443","DOIUrl":"https://doi.org/10.5500/wjt.v11.i11.443","url":null,"abstract":"<p><p>Glucocorticoids (GCs) have been the mainstay of immunosuppressive therapy in solid organ transplantation (SOT) for decades, due to their potent effects on innate immunity and tissue protective effects. However, some SOT centers are reluctant to administer GCs long-term because of the various related side effects. This review summarizes the advantages and disadvantages of GCs in SOT. PubMed and Scopus databases were searched from 2011 to April 2021 using search syntaxes covering \"transplantation\" and \"glucocorticoids\". GCs are used in transplant recipients, transplant donors, and organ perfusate solution to improve transplant outcomes. In SOT recipients, GCs are administered as induction and maintenance immunosuppressive therapy. GCs are also the cornerstone to treat acute antibody- and T-cell-mediated rejections. Addition of GCs to organ perfusate solution and pretreatment of transplant donors with GCs are recommended by some guidelines and protocols, to reduce ischemia-reperfusion injury peri-transplant. GCs with low bioavailability and high potency for GC receptors, such as budesonide, nanoparticle-mediated targeted delivery of GCs to specific organs, and combination use of dexamethasone with inducers of immune-regulatory cells, are new methods of GC application in SOT patients to reduce side effects or induce immune-tolerance instead of immunosuppression. Various side effects involving different non-targeted organs/tissues, such as bone, cardiovascular, neuromuscular, skin and gastrointestinal tract, have been noted for GCs. There are also potential drug-drug interactions for GCs in SOT patients.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 11","pages":"443-465"},"PeriodicalIF":0.0,"publicationDate":"2021-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/04/93/WJT-11-443.PMC8603633.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39694877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: Systematic review and meta-analysis.","authors":"Sreelakshmi Kotha,&nbsp;Bishoy Lawendy,&nbsp;Saira Asim,&nbsp;Charlene Gomes,&nbsp;Jeffrey Yu,&nbsp;Ani Orchanian-Cheff,&nbsp;George Tomlinson,&nbsp;Mamatha Bhat","doi":"10.5500/wjt.v11.i10.432","DOIUrl":"https://doi.org/10.5500/wjt.v11.i10.432","url":null,"abstract":"<p><strong>Background: </strong>Solid organ transplantation is a life-saving intervention for end-stage organ disease. Post-transplant diabetes mellitus (PTDM) is a common complication in solid organ transplant recipients, and significantly compromises long-term survival beyond a year.</p><p><strong>Aim: </strong>To perform a systematic review and meta-analysis to estimate incidence of PTDM and compare the effects of the 3 major immunosuppressants on incidence of PTDM.</p><p><strong>Methods: </strong>Two hundred and six eligible studies identified 75595 patients on Tacrolimus, 51242 on Cyclosporine and 3020 on Sirolimus. Random effects meta-analyses was used to calculate incidence.</p><p><strong>Results: </strong>Network meta-analysis estimated the overall risk of developing PTDM was higher with tacrolimus (OR = 1.4 95%CI: 1.0-2.0) and sirolimus (OR = 1.8; 95%CI: 1.5-2.2) than with Cyclosporine. The overall incidence of PTDM at years 2-3 was 17% for kidney, 19% for liver and 22% for heart. The risk factors for PTDM most frequently identified in the primary studies were age, body mass index, hepatitis C, and African American descent.</p><p><strong>Conclusion: </strong>Tacrolimus tends to exhibit higher diabetogenicity in the short-term (2-3 years post-transplant), whereas sirolimus exhibits higher diabetogenicity in the long-term (5-10 years post-transplant). This study will aid clinicians in recognition of risk factors for PTDM and encourage careful evaluation of the risk/benefit of different immunosuppressant regimens in transplant recipients.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 10","pages":"432-442"},"PeriodicalIF":0.0,"publicationDate":"2021-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/9c/WJT-11-432.PMC8529944.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39579852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors predicting futility of liver transplant in elderly recipients: A single-center experience.","authors":"Cerise Kleb,&nbsp;Muhammad Salman Faisal,&nbsp;Cristiano Quintini,&nbsp;Charles M Miller,&nbsp;K V Narayanan Menon,&nbsp;Jamak Modaresi Esfeh","doi":"10.5500/wjt.v11.i10.421","DOIUrl":"https://doi.org/10.5500/wjt.v11.i10.421","url":null,"abstract":"<p><strong>Background: </strong>As the population of the United States ages, there has been an increasing number of elderly patients with cirrhosis listed for transplant. Previous studies have shown variable results in terms of the relative survival benefit for elderly liver transplant (LT) recipients. There may be factors that are associated with a poor post-transplant outcome which may help determine which elderly patients should and should not be listed for LT.</p><p><strong>Aim: </strong>To identify factors associated with futility of transplant in elderly patients.</p><p><strong>Methods: </strong>This was a retrospective study of all patients above the age of 45 who underwent liver transplantation at our tertiary care center between January 2010 and March 2020 (<i>n</i> = 1019). \"Elderly\" was defined as all patients aged 65 years and older. Futile outcome was defined as death within 90 d of transplant. Logistic regression analysis was performed to determine what variables, if any were associated with futile outcome in elderly patients. Secondary outcomes such as one year mortality and discharge to facility (such as skilled nursing facility or long-term acute care hospital) were analyzed in the entire sample, compared across three age groups (45-54, 55-64, and 65 + years).</p><p><strong>Results: </strong>There was a total of 260 elderly patients who received LT in the designated time period. A total of 20 patients met the definition of \"futile\" outcome. The mean Model of End-Stage Liver Disease scores in the futile and non-futile group were not significantly different (21.78 in the futile group <i>vs</i> 19.66 in the \"non-futile\" group). Of the variables tested, only congestive heart failure was found to have a statistically significant association with futile outcome in LT recipients over the age of 65 (<i>P</i> = 0.001). Of these patients, all had diastolic heart failure with normal ejection fraction and at least grade I diastolic dysfunction as measured on echocardiogram. Patients aged 65 years and older were more likely to have the outcomes of death within 1 year of LT [hazard ratio: 1.937, confidence interval (CI): 1.24-3.02, <i>P</i> = 0.003] and discharge to facility (odds ratio: 1.94, CI: 1.4-2.8, <i>P</i> < 0.001) compared to patients in younger age groups.</p><p><strong>Conclusion: </strong>Diastolic heart failure in the elderly may be a predictor of futility post liver transplant in elderly patients. Elderly LT recipients may have worse outcomes as compared to younger patients.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 10","pages":"421-431"},"PeriodicalIF":0.0,"publicationDate":"2021-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/75/55/WJT-11-421.PMC8529943.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39668589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hemodynamic management in brain dead donors.","authors":"Chiara Lazzeri,&nbsp;Manuela Bonizzoli,&nbsp;Cristiana Guetti,&nbsp;Giorgio Enzo Fulceri,&nbsp;Adriano Peris","doi":"10.5500/wjt.v11.i10.410","DOIUrl":"https://doi.org/10.5500/wjt.v11.i10.410","url":null,"abstract":"<p><p>Donor management is the key in the complex donation process, since up to 20% of organs of brain death donors (DBD) are lost due to hemodynamic instability. This challenge is made more difficult due to the lack of strong recommendations on therapies for hemodynamic management in DBDs and more importantly to the epidemiologic changes in these donors who are becoming older and with more comorbidities (marginal donors). In the present manuscript we aimed at summarizing the available evidence on therapeutic strategies for hemodynamic management (focusing on vasoactive drugs) and monitoring (therapeutic goals). Evidence on management in elderly DBDs is also summarized. Donor management continues critical care but with different and specific therapeutic goals since the number of donor goals met is related to the number of organs retrieved and transplanted. Careful monitoring of selected parameters (possibly including serial echocardiography) is the clinical tool able to guarantee the achievement and maintaining of therapeutic goals. Despide worldwide differences, norepinephrine is the vasoactive of choice in most countries but, whenever higher doses (> 0.2 mcg/kg/min) are needed, a second vasoactive drug (vasopressin) is advisable. Hormonal therapy (desmopressin, corticosteroid and thyroid hormone) are suggested in all DBDs independently of hemodynamic instability. In the single patient, therapeutic regimen (imprimis vasoactive drugs) should be chosen also according to the potential organs retrievable (<i>i.e.</i> heart <i>vs</i> liver and kidneys).</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 10","pages":"410-420"},"PeriodicalIF":0.0,"publicationDate":"2021-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ef/e6/WJT-11-410.PMC8529942.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39668588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ABO incompatibility in renal transplantation.","authors":"Mahmoud Mohamed,&nbsp;Tara Sweeney,&nbsp;Duaa Alkhader,&nbsp;Mahmoud Nassar,&nbsp;Ahmed Alqassieh,&nbsp;Sofia Lakhdar,&nbsp;Nso Nso,&nbsp;Tibor Fülöp,&nbsp;Ahmed Daoud,&nbsp;Karim M Soliman","doi":"10.5500/wjt.v11.i9.388","DOIUrl":"https://doi.org/10.5500/wjt.v11.i9.388","url":null,"abstract":"<p><p>ABO blood group incompatibility (ABO-I) was historically considered an absolute contraindication to kidney transplantation due to the significant risk of acute antibody-mediated rejection and early graft loss. Nevertheless, the urge to minimize the gap between the candidates' number on the waitlist for kidney transplants and the available kidney donors encourage investigation into finding ways to use organs from ABO-I kidney donors, especially in the era of using more potent immunosuppression therapies. This review aims to discuss a general overview of ABO-I kidney transplantation and the different protocols adopted by some transplant centers to meaningfully overcome this barrier.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"11 9","pages":"388-399"},"PeriodicalIF":0.0,"publicationDate":"2021-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/95/WJT-11-388.PMC8465511.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39503460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}